“I did not want to be a victim.”
21 October 2026
Europe
An episode built around personal testimony from someone who refused to let their experience be flattened into a victim narrative on either side of the gender debate. For readers tracking the evidence base, the conversation touches on a recurring theme in detransition accounts: resistance to being used as a political symbol, whether by clinics, activists or critics. It matters because how these stories are told shapes guidelines, informed-consent standards and court findings across Europe, and because agency, not victimhood, is what many who have gone through medical transition and detransition say they actually want recognised.
This episode of Beyond Gender centres on a first-person account built around a single, pointed refusal: the guest did not want to be cast as a victim, despite an experience that would, in many tellings, be framed that way by default. Hosted by Stella O'Malley, Mia Hughes and Dr Bret Alderman, the conversation gives space for someone to describe navigating gender identity services, medical intervention, or its aftermath, on their own terms rather than through a script written by advocacy groups on any side of the debate. The refusal of a victim label is not incidental to this discussion; it is the argument. Much of the public conversation about youth gender medicine and detransition in Europe has been fought through competing narratives of harm and heroism, with individuals often recruited after the fact to illustrate a political point. A guest who resists that framing complicates both camps: it denies gender clinics a success story and denies critics a simple cautionary tale, insisting instead on a more complicated truth about agency, decision-making and recovery. That complication is exactly what matters for the evidence base. Systematic reviews commissioned in England, Sweden and Finland, along with the Cass Review in the UK, have repeatedly flagged how thin the long-term outcome data for paediatric gender medicine remains, and how little is known about the lived experience of those who stop or reverse treatment. First-person accounts that resist tidy categorisation are a reminder of why these reviews called for caution rather than certainty, and why clinical guidance across several European health systems has shifted toward more conservative, psychotherapy-first approaches. The episode also speaks to a quieter institutional pattern: the way health services, media and campaign groups have historically preferred narratives where someone is clearly harmed or clearly helped, because those stories are easier to mobilise. A guest who declines that role puts pressure on institutions to engage with ambiguity, something court decisions in several jurisdictions, including rulings on informed consent for adolescents, have increasingly had to grapple with directly. For a site tracking documented evidence rather than advocacy framing, the value of this conversation lies in what it withholds as much as what it states. It resists being slotted neatly into either a cautionary narrative about medical harm or a triumphant one about self-determination, and in doing so reflects the genuinely unsettled state of the clinical and legal record across Europe. Readers interested in how detransition narratives are constructed, contested and eventually absorbed into guidelines and judgments will find this an instructive case study in why the people at the centre of these stories so often resist having the story told for them.
